OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production leverages Chinese hamster ovary (CHO) cells due to their robustness in expressing complex proteins. Enhancing these processes involves adjusting various factors, including cell line engineering, media formulation, and bioreactor conditions. A key goal is to amplify antibody yield while reducing production expenses an